Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Closed Surgical Technique vs Modified Papilla Preservation Technique in treating interdental periodontal defects

Official title: Closed Surgical Technique Combined With i-PRF for the Treatment of Isolated Intrabony Periodontal Defects; a Randomized Clinical Trial

Run by Aristotle University Of Thessaloniki · NCT07919769 · Data updated 2026-11-12

This trial tests whether the closed surgical technique with i-PRF can improve healing for isolated interdental periodontal defects better than the modified papilla preservation technique with i-PRF in adults.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorAristotle University Of Thessaloniki
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Thessaloniki, Greece)
StatusRecruiting
StartedOctober 1, 2026
Main results expectedJuly 31, 2028
Study endsJuly 31, 2028
Registry record updatedNovember 5, 2026
Trial IDNCT07919769 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Systemically healthy adults with at least one interdental defect (CAL and PPD ≥6 mm, BOP) after non-surgical therapy, who smoke minimally or are non-smokers, and maintain good oral hygiene.

Probably not a fit

Patients with active periodontal inflammation, poor wound healing risk, heavy smoking (>10 cigarettes/day), pregnancy, or other exclusion criteria may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial compares two surgical approaches for treating isolated interdental periodontal defects: a closed surgical technique (CST) and a modified papilla preservation technique (MPPT), both with injectable platelet-rich fibrin (i-PRF). Participants have residual pockets with deep probing depths and signs of inflammation after non-surgical treatment. Outcomes include clinical attachment level gain, radiographic bone fill, and biomarker changes (VEGF, OPG, RANKL) over 12 months. Blood is drawn to prepare i-PRF, and standardized measurements are taken at baseline and follow-up visits. The study follows a structured visit schedule with initial screening, baseline surgery, and subsequent assessments to compare efficacy and safety.

Why it matters

Potential benefit: If successful, CST with i-PRF could offer better tissue preservation and attachment gain for patients with interdental defects.

How similar studies have gone: Previous approaches using papilla preservation and regenerative adjuncts have shown promise, but direct comparison with a closed tunnelling technique is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Systematically healthy subjects, not having consumed antibiotics 3 months before surgical periodontal treatment (baseline)
* Smokers \<10 cig/day, former smokers or no smokers
* Periodontal patients fulfilling non-surgical initial periodontal treatment at least 3 months before surgical periodontal treatment (baseline day) and presenting at least one residual pocket with PPD and CAL ≥6mm and bleeding on probing, located interproximally with intrerdental site ≥2mm.
* Compliant patients presenting high standards of oral hygiene (full mouth Plaque Index \<20%) strictly susceptible in Supportive Periodontal

Exclusion Criteria:

* Untreated active periodontal inflammation
* Poorly controlled systematic diseases
* Disorders compromise wound healing
* Bisphosphonate medications
* Patients under radiotherapy or chemotherapy
* Drug-induced gingival hyperplasia
* Pregnancy or lactation
* Poor compliance during steps 1 and 2 of cause-related periodontal treatment
* Compromised oral hygiene (full mouth Plaque Index \>30%),
* circumferential bone defect or narrow intrerdental site ≤2mm.

Where it's running

  • Dental School, Aristotle University, Dept of Preventive Dentistry, Periodontology and Implant Biology
    Thessaloniki, Greece, Greece
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.